Cryopreservation of biological materials law

Introduction

Cryopreservation refers to the process of preserving biological materials at extremely low temperatures to maintain their structural integrity and biological viability for extended periods. It is commonly used for preserving human cells, tissues, embryos, sperm, ova, stem cells, blood components, microorganisms and genetic materials.

Cryopreservation plays an important role in biotechnology, reproductive medicine, organ transplantation, pharmaceutical research and scientific experimentation. It enables hospitals, fertility centres, research laboratories and biotechnology companies to store biological materials for future medical or commercial applications.

However, the preservation of biological materials raises important legal questions concerning ownership, informed consent, confidentiality, storage duration, disposal, commercial use, negligence and institutional liability. These issues require coordination between healthcare regulations, biotechnology laws, privacy legislation and ethical guidelines.

Legal framework governing cryopreservation

Regulation of reproductive materials

Cryopreservation of sperm, eggs and embryos is particularly important in assisted reproductive technology (ART). In India, the Assisted Reproductive Technology (Regulation) Act, 2021 regulates ART clinics and banks.

The legislation establishes requirements concerning registration, storage, handling and utilisation of reproductive materials. It also addresses consent, record maintenance and restrictions on the use of stored reproductive materials.

The Assisted Reproductive Technology (Regulation) Rules, 2022 provide additional regulatory requirements for registered ART establishments.

Regulation of stem cells and biological tissues

Stem cells and other human biological materials are used in regenerative medicine, transplantation and experimental research. Their collection, processing, storage and clinical application must comply with applicable healthcare and research regulations.

In India, the National Guidelines for Stem Cell Research, 2017 provide an important framework for ethical and scientific supervision of stem cell research. They distinguish permissible research activities from prohibited or restricted clinical applications.

The Drugs and Cosmetics Act, 1940 and applicable rules may also become relevant where biological products fall within the regulatory definition of drugs or related regulated products.

Privacy and confidentiality

Biological samples may contain genetic information capable of identifying individuals or revealing inherited health conditions. Therefore, institutions must protect personal information and maintain appropriate confidentiality.

The Digital Personal Data Protection Act, 2023 establishes requirements for processing digital personal data, subject to its applicable commencement provisions and rules. Other relevant medical confidentiality and research ethics obligations must also be considered.

Major legal issues

Ownership and control of biological materials

One of the most significant legal questions is determining who controls cryopreserved biological materials.

Patients may provide biological samples for medical treatment or research, while hospitals and laboratories physically store and manage them. However, physical custody does not automatically establish unrestricted ownership or commercial rights.

Institutions should clearly define the rights and responsibilities of donors, patients, researchers and storage facilities through consent documents and storage agreements.

Informed consent

Cryopreservation requires appropriate consent explaining the purpose of collection, storage conditions, duration, future use and disposal arrangements.

In reproductive medicine, additional questions arise when couples separate, a donor withdraws consent or one partner dies. Such circumstances may create disputes over the continued storage or use of embryos and reproductive materials.

Negligence and storage failures

Cryogenic storage systems require continuous temperature monitoring, reliable equipment and emergency backup arrangements.

Equipment malfunction, power failure, inadequate maintenance or human error may damage stored biological materials. Depending on the circumstances, such incidents may result in contractual liability, professional negligence or consumer protection claims.

Commercial use and intellectual property

Biological samples may contribute to the development of pharmaceutical products, diagnostic technologies and biotechnology inventions.

However, ownership of a physical sample does not automatically provide ownership of every invention developed from it. Patent rights, contractual permissions and informed consent must be examined separately.

Important case laws

1. Evans v. United Kingdom (2007)

The European Court of Human Rights considered a dispute involving frozen embryos created through IVF. After the relationship ended, one partner withdrew consent to the continued use of the embryos.

The Court upheld the UK's consent framework, which required both parties' continuing consent before embryo use.

The judgment is significant because it demonstrates that cryopreserved embryos involve continuing consent rights and difficult legal questions concerning reproductive autonomy.

2. A.Z. v. B.Z. (2000)

The Supreme Judicial Court of Massachusetts examined a dispute involving frozen embryos following the breakdown of a relationship. One party sought to use the embryos despite the other's objection.

The Court declined to enforce an agreement requiring the unwilling party to become a parent.

The decision illustrates the importance of consent agreements and the protection of reproductive autonomy in cryopreservation disputes.

3. J.B. v. M.B. (2001)

The Supreme Court of New Jersey considered the disposition of frozen embryos following a divorce. It recognised the importance of the parties' reproductive autonomy and held that an individual's decision not to become a parent should generally receive substantial protection.

The case provides important guidance concerning contractual arrangements and consent withdrawal in embryo storage.

4. Parrillo v. Italy (2015)

The European Court of Human Rights considered whether an individual had a right under Article 8 of the European Convention on Human Rights to donate embryos created through IVF for scientific research.

The Court recognised that the applicant's decision concerned private life but found no violation in Italy's prohibition on embryo donation for research in the circumstances.

The judgment demonstrates the relationship between reproductive autonomy, embryo preservation and national restrictions on scientific research.

5. Moore v. Regents of the University of California (1990)

The Supreme Court of California examined the commercial use of biological materials obtained from a patient. It rejected the conversion claim concerning the excised cells but recognised potential duties relating to informed consent and disclosure of financial interests.

The decision is relevant to cryopreservation because stored human tissues and cells may later contribute to valuable scientific or commercial developments.

Institutional responsibilities and safeguards

Hospitals, fertility centres, tissue banks and research laboratories should establish comprehensive legal and operational procedures.

Important safeguards include:

Obtaining documented and informed consent.

Maintaining accurate records of sample origin and ownership-related rights.

Establishing clear storage duration and disposal policies.

Maintaining continuous temperature monitoring and backup systems.

Protecting genetic and medical information.

Establishing procedures for withdrawal of consent and disputes.

Maintaining insurance and equipment maintenance records.

Ensuring that commercial research complies with applicable permissions.

Institutions should also maintain separate procedures for reproductive materials, clinical tissues and research specimens because their legal requirements may differ.

Conclusion

Cryopreservation of biological materials is an important component of modern biotechnology and medical science. It supports fertility treatment, regenerative medicine, transplantation and long-term scientific research. However, it creates complex legal questions involving consent, ownership, privacy, negligence and commercial exploitation. The decisions in Evans v. United Kingdom, J.B. v. M.B. and Parrillo v. Italy demonstrate the importance of reproductive autonomy and consent in embryo preservation. A balanced legal framework must protect the rights of individuals while ensuring scientific reliability, institutional accountability and responsible management of biological materials.